[ad_1] Aimovig is a development of Novartis and Amgen. The launch in the US has been unprecedented, said Novartis boss Vas Narasimhan, who calls it a good omen for the launch in …
Read More »Antibodies against migraine admitted | PHARMACY ADHOC
Risk of infarction higher due to migraine? : Migraine sufferers appear to be more susceptible to vascular disease
[ad_1] Increased Risk: People with migraines are more likely to develop heart attacks, strokes, and thromboses. Two large studies now come to this conclusion. As a result, the risk of such vascular …
Read More »